Therapeutic Drug Monitoring (TDM) in Renal Transplant (RT): Reasons to Choose the LC-MS/MS Method

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Chromatography & Separation Techniques

• Publication date

  2012-03-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.4172/2157-7064.1000E101
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The current role of liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs.

  2011cited by this paper
• Falsely elevated whole‐blood tacrolimus concentrations in a kidney‐transplant patient: potential hazards

  2010cited by this paper
• Ultra Fast Liquid Chromatography-Tandem Mass Spectrometry Routine Method for Simultaneous Determination of Cyclosporin A, Tacrolimus, Sirolimus, and Everolimus in Whole Blood Using Deuterated Internal Standards for Cyclosporin A and Everolimus

  2010cited by this paper
• Therapeutic monitoring of tacrolimus: aberrant results by an immunoassay with automated pretreatment.

  2010cited by this paper
• Review of the newest HPLC methods with mass spectrometry detection for determination of immunosuppressive drugs in clinical practice.

  2009cited by this paper
• Falsely Increased Blood Tacrolimus Concentrations Using the ACMIA Assay Due to Circulating Endogenous Antibodies in a Liver Transplant Recipient: A Tentative Approach to Obtaining Reliable Results

  2009cited by this paper
• Robust, High-Throughput LC-MS/MS Method for Therapeutic Drug Monitoring of Cyclosporine, Tacrolimus, Everolimus, and Sirolimus in Whole Blood

  2009influential reference
• Therapeutic Drug Monitoring (TDM)

  2008cited by this paper
• Crossreactivity of Isolated Everolimus Metabolites With the Innofluor Certican Immunoassay for Therapeutic Drug Monitoring of Everolimus

  2007cited by this paper
• Inclusion of MPA and in a rapid multi-drug LC-tandem mass spectrometric method for simultaneous determination of immunosuppressants.

  2006cited by this paper
• Sensitive, High Throughput HPLC-MS/MS Method With On-line Sample Clean-up for Everolimus Measurement

  2006cited by this paper
• The role of therapeutic drug monitoring in individualizing immunosuppressive drug therapy: recent developments.

  2006cited by this paper
• Simultaneous determination of everolimus and cyclosporine concentrations by HPLC with ultraviolet detection.

  2006cited by this paper
• Pharmacokinetic Considerations Relating to Tacrolimus Dosing in the Elderly

  2005cited by this paper
• Effects of Hematocrit Value on Microparticle Enzyme Immunoassay of Tacrolimus Concentration in Therapeutic Drug Monitoring

  2005cited by this paper
• Effective Use of Liquid Chromatography-Mass Spectrometry (LC/MS) in the Routine Clinical Laboratory for Monitoring Sirolimus, Tacrolimus, and Cyclosporine

  2005cited by this paper
• Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era

  2004cited by this paper
• Rapid simultaneous quantification of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry.

  2004cited by this paper
• Therapeutic drug monitoring of immunosuppressant drugs by high-performance liquid chromatography-mass spectrometry.

  2004cited by this paper
• Comparison of Liquid Chromatography-Tandem Mass Spectrometry with a Commercial Enzyme-Multiplied Immunoassay for the Determination of Plasma MPA in Renal Transplant Recipients and Consequences for Therapeutic Drug Monitoring

  2004cited by this paper
• Therapeutic drug monitoring of immunosuppressant drugs in clinical practice.

  2002cited by this paper
• Strategies to improve long-term outcomes after renal transplantation.

  2002cited by this paper
• International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology Working Group on Immunosuppressive Drug Monitoring

  2002cited by this paper
• Therapeutic Monitoring of Tacrolimus Concentrations in Blood: Semi-Automated Extraction and Liquid Chromatography-Electrospray Ionization Mass Spectrometry

  2001cited by this paper
• Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants.

  2000cited by this paper
• Quantification of free mycophenolic acid by high-performance liquid chromatography-atmospheric pressure chemical ionisation tandem mass spectrometry.

  2000cited by this paper
• Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific?

  1999cited by this paper
• Analytical goals in therapeutic drug monitoring.

  1998cited by this paper
• Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites.

  1984cited by this paper

• Clinical laboratory diagnostics of immunosuppressants: One laboratory’s journey

  2015cites this paper